Skip to main content
# Title Research Member Research Year
61 Circulating hematopoietic stem cells, endothelial
progenitor cells and cancer stem cells in
hepatocellular carcinoma patients: contribution to
diagnosis and prognosis
Dr. Asmaa Mohamed Zahran Omar 2019
62 Assesment OF complement regulatory protients CD55 and CD59 on erythocytes in Betathalassemia major patients Dr. Asmaa Mohamed Zahran Omar 2019
63 Circulating hematopoietic stem cells, endothelial
progenitor cells and cancer stem cells in
hepatocellular carcinoma patients: contribution to
diagnosis and prognosis
Dr. Asmaa Mohamed Zahran Omar 2019
64 Long-Term Evaluation of Imatinib´s Effect on Bone
Marrow Fibrosis in Patients with Chronic Myeloid
Leukemia
Prof. Hosny Badrawy Hamed Omran 2019
65 Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients Dr. Iman Hassan Ahmed Hamada 2019
66 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Asmaa Ahmed Mohamed ahmed 2019
67 Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) Prof. Eman Massad Zaki El-Hefny 2019
68 The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia Prof. Eman Massad Zaki El-Hefny 2019
69 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Dr. Asmaa Mohamed Zahran Omar 2019
70 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Dr. Asmaa Mohamed Zahran Omar 2019